Works about CANCER immunotherapy

Results: 2427

CAR-T-Zellen: Vielversprechende Therapieoption für B-Zell-Malignome.

Published in:

Trillium-Diagnostik, 2024, v. 22, n. 4, p. 292, doi. 10.47184/td.2024.04.08

By:

Friedrich, Maik;
Sack, Ulrich

Publication type:

Article

Localized Multi-Component Delivery Platform Generates Local and Systemic Anti-Tumor Immunity.

Published in:

Advanced Functional Materials, 2017, v. 27, n. 5, p. n/a, doi. 10.1002/adfm.201604366

By:

Acharya, Abhinav P.;
Sinha, Mantosh;
Ratay, Michelle L.;
Ding, Xiaochu;
Balmert, Stephen C.;
Workman, Creg J.;
Wang, Yadong;
Vignali, Dario A. A.;
Little, Steven R.

Publication type:

Article

Enzyme-Catalyzed Formation of Supramolecular Hydrogels as Promising Vaccine Adjuvants.

Published in:

Advanced Functional Materials, 2016, v. 26, n. 11, p. 1822, doi. 10.1002/adfm.201505188

By:

Wang, Huaimin;
Luo, Zichao;
Wang, Youzhi;
He, Tao;
Yang, Chengbiao;
Ren, Chunhua;
Ma, Linsha;
Gong, Changyang;
Li, Xingyi;
Yang, Zhimou

Publication type:

Article

Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells.

Published in:

Biotechnology Letters, 2007, v. 29, n. 3, p. 351, doi. 10.1007/s10529-006-9260-y

By:

Tae-Hyung Lee;
Young-Hun Cho;
Min-Geol Lee

Publication type:

Article

Utilizing bacterial flagellins against infectious diseases and cancers.

Published in:

Antonie van Leeuwenhoek, 2014, v. 105, n. 2, p. 275, doi. 10.1007/s10482-013-0075-2

By:

Tarahomjoo, Shirin

Publication type:

Article

Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.

Published in:

World Journal of Urology, 2017, v. 35, n. 3, p. 367, doi. 10.1007/s00345-016-1885-4

By:

Pham, M.;
Apolo, A.;
Santis, M.;
Galsky, M.;
Leibovich, B.;
Pisters, L.;
Siefker-Radtke, A.;
Sonpavde, G.;
Steinberg, G.;
Sternberg, C.;
Tagawa, S.;
Weizer, A.;
Woods, M.;
Milowsky, M.

Publication type:

Article

Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?

Published in:

World Journal of Urology, 2017, v. 35, n. 2, p. 237, doi. 10.1007/s00345-016-1856-9

By:

Golabek, Thomasz;
Palou, Joan;
Rodríguez, Oscar;
Gaya, Josep;
Breda, Alberto;
Villavicencio, Humberto

Publication type:

Article

Immune checkpoint inhibitors: a new frontier in bladder cancer.

Published in:

World Journal of Urology, 2016, v. 34, n. 1, p. 49, doi. 10.1007/s00345-015-1709-y

By:

Kates, Max;
Sopko, Nikolai;
Matsui, Hotaka;
Drake, Charles;
Hahn, Noah;
Bivalacqua, Trinity

Publication type:

Article

Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Published in:

World Journal of Urology, 2014, v. 32, n. 3, p. 631, doi. 10.1007/s00345-014-1293-6

By:

Kim, Dae;
Karam, Jose;
Wood, Christopher

Publication type:

Article

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy.

Published in:

World Journal of Urology, 2014, v. 32, n. 1, p. 31, doi. 10.1007/s00345-013-1033-3

By:

Bedke, Jens;
Gouttefangeas, Cécile;
Singh-Jasuja, Harpreet;
Stevanović, Stefan;
Behnes, Carl-Ludwig;
Stenzl, Arnulf

Publication type:

Article

Novel options for the treatment of castration-resistant prostate cancer.

Published in:

World Journal of Urology, 2012, v. 30, n. 4, p. 495, doi. 10.1007/s00345-011-0796-7

By:

Ohlmann, Carsten-H.;
Merseburger, Axel;
Suttmann, Henrik;
Schilling, David;
Trojan, Lutz;
Kempkensteffen, Carsten;
Corvin, Stefan;
Mathers, Michael;
Bastian, Patrick

Publication type:

Article

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.

Published in:

World Journal of Urology, 2011, v. 29, n. 3, p. 361, doi. 10.1007/s00345-011-0673-4

By:

Herrmann, E.;
Marschner, N.;
Grimm, M.;
Ohlmann, C.;
Hutzschenreuter, U.;
Overkamp, F.;
Groschek, M.;
Blumenstengel, K.;
Pühse, G.;
Steiner, T.

Publication type:

Article

In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.

Published in:

Amino Acids, 2012, v. 42, n. 4, p. 1349, doi. 10.1007/s00726-010-0830-x

By:

Baloria, Urvashi;
Akhoon, Bashir;
Gupta, Shishir;
Sharma, Sujata;
Verma, Vijeshwar

Publication type:

Article

A Literature Analysis of Prognostic Factors for Response and Quality of Response of Patients with Renal Cell Carcinoma to Interleukin-2-Based Therapy.

Published in:

Oncology, 2001, v. 61, n. 2, p. 91, doi. 10.1159/000055359

By:

Elias, Laurence;
Hunt, William C.

Publication type:

Article

Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies.

Published in:

Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00781-5

By:

Imakita, Takuma;
Fujita, Kohei;
Ito, Takanori;
Saito, Zentaro;
Oi, Issei;
Kanai, Osamu;
Tachibana, Hiromasa;
Sawai, Satoru;
Mio, Tadashi

Publication type:

Article

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer.

Published in:

NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00172-5

By:

Jiao, Xi;
Wei, Xin;
Li, Shuang;
Liu, Chang;
Chen, Huan;
Gong, Jifang;
Li, Jian;
Zhang, Xiaotian;
Wang, Xicheng;
Peng, Zhi;
Qi, Changsong;
Wang, Zhenghang;
Wang, Yujiao;
Wang, Yanni;
Zhuo, Na;
Zhang, Henghui;
Lu, Zhihao;
Shen, Lin

Publication type:

Article

Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.

Published in:

NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00162-7

By:

Smith, Corey;
McGrath, Margaret;
Neller, Michelle A.;
Matthews, Katherine K.;
Crooks, Pauline;
Le Texier, Laetitia;
Panizza, Benedict;
Porceddu, Sandro;
Khanna, Rajiv

Publication type:

Article

PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma.

Published in:

NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00147-6

By:

Maekawa, Naoya;
Konnai, Satoru;
Nishimura, Maki;
Kagawa, Yumiko;
Takagi, Satoshi;
Hosoya, Kenji;
Ohta, Hiroshi;
Kim, Sangho;
Okagawa, Tomohiro;
Izumi, Yusuke;
Deguchi, Tatsuya;
Kato, Yukinari;
Yamamoto, Satoshi;
Yamamoto, Keiichi;
Toda, Mikihiro;
Nakajima, Chie;
Suzuki, Yasuhiko;
Murata, Shiro;
Ohashi, Kazuhiko

Publication type:

Article

Imaging of tumour response to immunotherapy.

Published in:

European Radiology Experimental, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41747-019-0134-1

By:

Dromain, Clarisse;
Beigelman, Catherine;
Pozzessere, Chiara;
Duran, Rafael;
Digklia, Antonia

Publication type:

Article

Positron emission tomography in breast cancer: <sup>18</sup>F- FDG and other radiopharmaceuticals.

Published in:

European Journal of Hybrid Imaging, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41824-018-0039-x

By:

Iakovou, Ioannis;
Giannoula, Evanthia;
Gkantaifi, Areti;
Levva, Sofia;
Frangos, Savvas

Publication type:

Article

Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy–Induced Diabetes Mellitus.

Published in:

Journal of the Endocrine Society, 2020, v. 4, n. 10, p. 1, doi. 10.1210/jendso/bvaa114

By:

Quandt, Zoe;
Coupe, Catherine;
Anderson, Mark;
Uihlein, Alexander;
Young, Arabella

Publication type:

Article

Accentuating the Positive: Do Trials Give Unrealistic Expectations of Long-Term Survival?

Published in:

2019

By:

Kiely, Belinda E;
Stockler, Martin R

Publication type:

Editorial

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.

Published in:

Immunopharmacology & Immunotoxicology, 2016, v. 38, n. 1, p. 50, doi. 10.3109/08923973.2015.1100204

By:

Alrifai, Doraid;
Sarker, Debashis;
Maher, John

Publication type:

Article

Shark cartilage 14 kDa protein as a dendritic cells activator.

Published in:

Immunopharmacology & Immunotoxicology, 2015, v. 37, n. 2, p. 165, doi. 10.3109/08923973.2015.1006370

By:

Safari, Elahe;
Hassan, Zuhair M.;
Moazzeni, Seyed Mohammad

Publication type:

Article

Development of assay platforms for in vitro screening of Treg modulating potential of pharmacological compounds.

Published in:

Immunopharmacology & Immunotoxicology, 2015, v. 37, n. 1, p. 63, doi. 10.3109/08923973.2014.977449

By:

Pedersen, Anders Elm;
Holmstrøm, Kim;
Jørgensen, Flemming;
Jensen, Simon S.;
Gad, Monika

Publication type:

Article

Combination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancer.

Published in:

Turkish Journal of Medical Sciences, 2016, v. 46, n. 2, p. 518, doi. 10.3906/sag-1410-61

By:

JAHANGIRI, Shervin;
ABTAHI FROUSHANI, Seyyed Meysam;
DELIREZH, Norouz

Publication type:

Article

Primary anorectal malignant melanoma: rare but highly lethal malignancy.

Published in:

Turkish Journal of Medical Sciences, 2012, v. 42, n. S2, p. 1513, doi. 10.3906/sag-1202-62

By:

SÖNMEZ, Özlem;
ÜYETÜRK, Ümmügül;
HELVACI, Kaan;
TÜRKER, İbrahim;
KÖŞ, Fahriye Tuğba;
DOĞAN, Lütfi;
BUDAKOĞLU, Burçin;
ARSLAN, Ülkü YALÇINTAŞ;
ÖKSÜZOĞLU, Ömür Berna ÇAKMAK

Publication type:

Article

Immune checkpoint inhibitors for urothelial carcinoma.

Published in:

Investigative & Clinical Urology, 2018, v. 59, n. 5, p. 285, doi. 10.4111/icu.2018.59.5.285

By:

Hyung Suk Kim;
Ho Kyung Seo

Publication type:

Article

Immune checkpoint blockade therapy for bladder cancer treatment.

Published in:

Investigative & Clinical Urology, 2016, v. 57, p. S98, doi. 10.4111/icu.2016.57.S1.S98

By:

Jayoung Kim

Publication type:

Article

Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?

Published in:

Molecular & Cellular Oncology, 2019, v. 6, n. 3, p. N.PAG, doi. 10.1080/23723556.2019.1600349

By:

Bouwstra, Renee;
van Meerten, Tom;
Bremer, Edwin

Publication type:

Article

Adoptive cell transfer: new perspective treatment in veterinary oncology.

Published in:

Acta Veterinaria Scandinavica, 2018, v. 60, n. 1, p. N.PAG, doi. 10.1186/s13028-018-0414-4

By:

Bujak, Joanna Katarzyna;
Pingwara, Rafał;
Nelson, Michelle Hase;
Majchrzak, Kinga

Publication type:

Article

The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Squamous Cell Carcinoma of the Head and Neck (HNSCC).

Published in:

International Journal of Prosthodontics, 2020, v. 33, n. 1, p. 90

By:

Sadowsky, Steven

Publication type:

Article

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma.

Published in:

Journal of Extracellular Vesicles, 2013, v. 2, p. 1, doi. 10.3402/jev.v2i0.22492

By:

Mahaweni, Niken M.;
Kaijen-Lambers, Margaretha E.H.;
Dekkers, Jacqueline;
Aerts, Joachim G.J.V.;
Hegmans, Joost P.J.J.

Publication type:

Article

Oral Session 29 (Plaza Ballroom): Therapy: targeting and loading.

Published in:: 2013
Publication type:: Abstract

Cancer immunotherapy - a promising approach.

Published in:

Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2018, v. 59, n. 8, p. 825

By:

Gyles, Carlton

Publication type:

Article

Transient Treg depletion enhances therapeutic anti-cancer vaccination.

Published in:

Immunity, Inflammation & Disease, 2017, v. 5, n. 1, p. 16, doi. 10.1002/iid3.136

By:

Fisher, Scott A.;
Aston, Wayne J.;
Chee, Jonathan;
Khong, Andrea;
Cleaver, Amanda L.;
Solin, Jessica N.;
Ma, Shaokang;
Lesterhuis, W. Joost;
Dick, Ian;
Holt, Robert A.;
Creaney, Jenette;
Boon, Louis;
Robinson, Bruce;
Lake, Richard A.

Publication type:

Article

Current applications and future prospects of nanotechnology in cancer immunotherapy.

Published in:

Cancer Biology & Medicine, 2019, v. 16, n. 3, p. 486, doi. 10.20892/j.issn.2095-3941.2018.0493

By:

Sen Yan;
Peng Zhao;
Tingting Yu;
Ning Gu

Publication type:

Article

Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle.

Published in:

Cancer Biology & Medicine, 2019, v. 16, n. 2, p. 205, doi. 10.20892/j.issn.2095-3941.2018.0141

By:

Xiubao Ren

Publication type:

Article

Key questions about the checkpoint blockade-are microRNAs an answer?

Published in:

Cancer Biology & Medicine, 2018, v. 15, n. 2, p. 103, doi. 10.20892/j.issn.2095-3941.2018.0006

By:

Dragomir, Mihnea;
Baoqing Chen;
Xiao Fu;
Calin, George A.

Publication type:

Article

PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy.

Published in:

Cancer Biology & Medicine, 2018, v. 15, n. 2, p. 116, doi. 10.20892/j.issn.2095-3941.2017.0086

By:

Long Jia;
Qi Zhang;
Rongxin Zhang

Publication type:

Article

Assays for predicting and monitoring responses to lung cancer immunotherapy.

Published in:

Cancer Biology & Medicine, 2015, v. 12, n. 2, p. 87, doi. 10.7497/j.issn.2095-3941.2015.0019

By:

Teixidó, Cristina;
Karachaliou, Niki;
González-Cao, Maria;
Morales-Espinosa, Daniela;
Rosell, Rafael

Publication type:

Article

PRAME Gene Expression in Acute Leukemia and Its Clinical Significance.

Published in:

Cancer Biology & Medicine, 2012, v. 9, n. 1, p. 73, doi. 10.3969/j.issn.2095-3941.2012.01.013

By:

Kai Ding;
Xiao-ming Wang;
Rong Fu;
Er-bao Ruan;
Hui Liu;
Zong-hong Shao

Publication type:

Article

The siRNA‐mediated downregulation of PD‐1 alone or simultaneously with CTLA‐4 shows enhanced in vitro CAR‐T‐cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.

Published in:

Experimental Dermatology, 2018, v. 27, n. 7, p. 769, doi. 10.1111/exd.13678

By:

Simon, Bianca;
Harrer, Dennis C.;
Schuler‐Thurner, Beatrice;
Schaft, Niels;
Schuler, Gerold;
Dörrie, Jan;
Uslu, Ugur

Publication type:

Article

Therapeutic implications of melanoma heterogeneity.

Published in:

Experimental Dermatology, 2016, v. 25, n. 7, p. 497, doi. 10.1111/exd.13002

By:

Hachey, Stephanie J.;
Boiko, Alexander D.

Publication type:

Article

PD‐L1 expression in tumour‐infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.

Published in:

Histopathology, 2018, v. 73, n. 3, p. 386, doi. 10.1111/his.13527

By:

Ren, Min;
Dai, Bo;
Kong, Yun‐Yi;
Lv, Jiao‐Jie;
Cai, Xu

Publication type:

Article

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01399

By:

Yan, Dehong;
Adeshakin, Adeleye O.;
Xu, Meichen;
Afolabi, Lukman O.;
Zhang, Guizhong;
Chen, Youhai H.;
Wan, Xiaochun

Publication type:

Article

L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01321

By:

Watson, H. Angharad;
Durairaj, Ruban R. P.;
Ohme, Julia;
Alatsatianos, Markella;
Almutairi, Hanan;
Mohammed, Rebar N.;
Vigar, Miriam;
Reed, Sophie G.;
Paisey, Stephen J.;
Marshall, Christopher;
Gallimore, Awen;
Ager, Ann

Publication type:

Article

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01126

By:

Zhang, Yingting;
Springfield, Ryan;
Chen, Siyang;
Li, Xin;
Feng, Xiaotian;
Moshirian, Rosa;
Yang, Rirong;
Yuan, Weiming

Publication type:

Article

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00925

By:

Vigano, Selena;
Alatzoglou, Dimitrios;
Irving, Melita;
Ménétrier-Caux, Christine;
Caux, Christophe;
Romero, Pedro;
Coukos, George

Publication type:

Article

CTL-Derived Exosomes Enhance the Activation of CTLs Stimulated by Low-Affinity Peptides.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01274

By:

Wu, Shu-Wei;
Li, Lei;
Wang, Yan;
Xiao, Zhengguo

Publication type:

Article